Sentences with phrase «immunotherapy clinical»

This page features information on breast cancer and immunotherapy clinical trials for breast cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to people with breast cancer.

This may be best addressed by a tailored development paradigm,» says CIC Executive Committee member and a lead investigator in the ipilimumab clinical development program Jedd D. Wolchok, M.D., Ph.D., who is director of the Immunotherapy Clinical Trials Program at Memorial Sloan - Kettering Cancer Center in New York City.

Immune - related progressive disease is a measure of effectiveness used in cancer immunotherapy clinical trials.

Appointments with clinical trial navigators will be available throughout the day to help you find immunotherapy clinical trials, connect with study sites, and answer questions.

In addition, a growing number of immunotherapy clinical trials are in place to test this groundbreaking approach on other cancers like lymphoma, multiple myeloma, and for solid tumors, through trials in glioblastoma, mesothelioma, and ovarian and pancreatic cancer.

Immune - related complete response is a measure of effectiveness used in cancer immunotherapy clinical trials.

She enrolled in an immunotherapy clinical trial to help keep her body cancer - free in the future.

This page features information on pancreatic cancer and immunotherapy clinical trials for pancreatic cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to pancreatic cancer patients.

This page features information on esophageal cancer and immunotherapy clinical trials for esophageal cancer patients, and highlights the Cancer Research Institute's role in working to develop immune - based treatments for esophageal cancer.

Melanoma has long been considered a promising target for immunotherapy and has been a major focus of immunotherapy clinical development efforts.

This page features information on cervical cancer and immunotherapy clinical trials for cervical cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to people with cervical cancer.

This page features information on colorectal cancer and immunotherapy clinical trials for colorectal cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to people with this kind of cancer.

This page features information on head and neck cancer and immunotherapy clinical trials for head and neck cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patients.

This page features information on liver cancer and immunotherapy clinical trials for liver cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to liver cancer patients.

This page features information on leukemia and immunotherapy clinical trials for leukemia patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based treatments to both children and adults with leukemia.

Building on clinical data from several single - agent immunotherapy clinical trials, and by engaging scientists with unique and complementary expertise from eight institutions and three industry partners, the BEAT - HIV Collaboratory's central mission will be to develop and test innovative combined immunotherapy strategies to eradicate and / or permanently suppress HIV replication in the absence of ART.

This page features information on multiple myeloma and immunotherapy clinical trials for multiple myeloma patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to people with multiple myeloma.

The Clinical Accelerator network includes approximately 80 of the world's leading physician - scientists with expertise in tumor immunology and cancer immunotherapy clinical trials, immune monitoring, and correlative research.

You can also view available immunotherapy clinical trials using our Clinical Trial Finder.

Go to our Cancer Immunotherapy Clinical Trial Finder to find clinical trials of immunotherapies for ovarian cancer that are currently enrolling patients.

In Allison's office, there's a drawing of him playing harmonica, captioned «The Cancer Immunotherapy Clinical Trial Blues.»

Not exact matches

With a critical mass of 450,000 patients annually among them, the six centers have agreed to combine their efforts on planning clinical trials in immunotherapy, recruit patients quickly, and share the information learned — which could be the single biggest factor in speeding up drug development.

«It also brings in the question of diet,» says Wargo, who is now working on new clinical studies on the microbiome with the Parker Institute for Cancer Immunotherapy.

HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their option to purchase additional shares, at a public offering price of $ 7.50 per share.

Speaking of checkpoint inhibitor drugs... Merck's star cancer immunotherapy treatment Keytruda is facing some troubling clinical trial incidents which have now compelled the Food and Drug Administration (FDA) to halt three studies of the drug in multiple myeloma, a rare blood cancer, after a number of patient deaths.

But while thousands of clinical trials on immunotherapy drugs, of which many are predicted to fail, are springing up, the depth of information on neoantigen vaccines is much shallower: Just two studies on neoantigen vaccines for melanoma, recently profiled in Nature, were completed last year in Boston and Germany.

HOUSTON, April 17, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $ 7.50 per share.

HOUSTON, April 16, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock.

Bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.

As we explained in our ASCO primer, pharma giants like Merck (mrk) and Bristol - Myers Squibb (bmy) and biotechs like Juno (juno) and Kite Pharma (kite) had a lot to prove through their clinical trial updates on experimental immunotherapies.

«What set Flatiron apart was that it was able to create regulatory grade, real - world data,» O'Day tells Fortune — data that O'Day claims is so well curated, that it «could have theoretically replaced the «control» arm» of one of Roche's own clinical trials for the cancer immunotherapy drug Tecentriq.

Clinical progress in cancer immunotherapy is driving career, collaboration, and leadership opportunities.

These attention - getting stories about cancer immunotherapy underline the vast career opportunities in academic, clinical, and industry research for those entering this field.

Cancer immunotherapy can produce durable clinical responses, but only in a subset of patients.

At Mayo, some immunologists work on basic research and others lean more toward the clinical applications of immunotherapy.

In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease's progression.

In a head - to - head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers found that people with squamous - non-small cell lung cancer who received nivolumab lived, on average, 3.2 months longer than those receiving chemotherapy.

«We believe these studies and clinical trials that combine immunotherapy with chemotherapy are advancing efforts toward better clinical care and more positive outcomes for our patients at CTCA,» said Dr. Vivek Khemka, Medical Oncologist, CTCA at Western and the WCLC study abstract's principal investigator and senior author.

«There are certainly challenges to overcome for clinical application of this kind of immunotherapy, but the newly published data are an important milestone in immunotherapy targeting solid tumors that have eluded other treatments.»

In fact, for some types of cancer, clinical trials of immunotherapy have reported complete remission in 90 percent of cases.

In clinical trials, immunotherapy drugs have demonstrated strong cancer - fighting abilities.

«It will be much more powerful than the antibodies,» says Timothy Chan, who does clinical research in immunotherapy at Memorial Sloan Kettering Cancer Center in New York City.

«Clinical trial using immunotherapy drug combinations to treat lung cancer appears safe.»

As Scientific American reported earlier this year, more than half of the current cancer clinical trials do incorporate some form of immunotherapy but still oncologists are often only in the early stages of understanding how to use such treatment on a larger scale.

Roche has four biologic cancer immunotherapy molecules in clinical trials that could work in powerful combinations with each other or with current drugs, says William Pao, global head of oncology discovery in Basel.

She notes that biotech firms are investing heavily in immunotherapy research, and about 40 percent of the roughly 6,000 cancer clinical trials taking place in the United States today include some form of immunotherapy.

Schlom, of the National Cancer Institute, says the next challenge for researchers is to find ways to combine different immunotherapy drugs into single treatments and measure their efficacy in clinical trials.

Nearly 80 percent of peanut - allergic preschool children successfully incorporated peanut - containing foods into their diets after receiving peanut oral immunotherapy (OIT), a clinical trial has found.

Tumors typically have a repertoire of molecular defenses they can use to suppress or evade immune attacks, which is why cancer vaccines and immunotherapies have had mixed results in clinical trials to date.

Priscilla N. Kelly Associate Editor Education: B.Sc., University of Western Australia; Ph.D., University of Melbourne Areas of responsibility: Preclinical development, translational medicine, cancer immunotherapy, drug discovery, clinical trials, gene and cell therapy E-Mail: [email protected]